iPS cells are the abbreviation for induced Pluripotent Stem cells, derived from their English name. Professor Shinya Yamanaka of Kyoto University, who developed this product, was awarded the 2012 Nobel Prize in Physiology or Medicine for his research findings. iPS Coin aims to establish a platform related to iPS cells. By leveraging this platform, they aim to promote data collection, large-scale production of iPS cells, reduce costs, and globally advance treatments based on iPS cells.
